XRTX - Latest News
XORTX Therapeutics Inc. (XRTX), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $2.8M. Beta to the broader market is 0.08.
The article list below shows the most recent XRTX headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent XRTX Headlines
XORTX Outlines Anticipated Health Canada Clinical Trial Application for XRx-026 for Gout
globenewswire.com - Oct 8, 2026
● Clinical Trial Application planned for filing with Health Canada, extending the Company's international regulatory strategy for gout program XRx-026
XORTX Announces Planned FDA IND Submission for XRx-026 Gout Program Using XORLO™, Targeting USD$700M+ U.S. Gout Market Opportunity
globenewswire.com - Sep 18, 2026
Investigational New Drug application planned for submission to the U. S.
XORTX Announces Initiation of Clinical and Commercial Manufacturing of XORLO™
globenewswire.com - Sep 10, 2026
● Contract manufacturing of GMP drug substance and commercial-scale tablets to support the XRX-OXY-102 clinical study and future US FDA marketing appr
XORTX Re-Engages Investor Relations Program
globenewswire.com - Sep 8, 2026
CALGARY, Alberta, Sept. 08, 2026 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc.
XORTX Announces Termination and Postponement of Investor Relations Program
globenewswire.com - Aug 28, 2026
CALGARY, Alberta, Aug. 28, 2026 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc.
How News Affects XRTX Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track XRTX's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked XRTX news questions
- What is the latest XRTX news headline?
- The most recent XRTX headline (Oct 8, 2026) is "XORTX Outlines Anticipated Health Canada Clinical Trial Application for XRx-026 for Gout". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the XRTX news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What XRTX news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual XRTX options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.